Literature DB >> 14636961

Brain imaging studies in human addicts.

Mark R C Daglish1, David J Nutt.   

Abstract

Addiction provides fertile ground for the application of the tools of functional neuroimaging. They can be divided into studies of neural activity and neurotransmitter function. Using the former, both opiates and stimulants cause a global decrease in brain metabolism. Against this background, acute doses have still been shown to produce relative increases in brain activation in specific regions, e.g., anterior cingulate, thalamus, and amygdala. These are also regions frequently found with cue-exposure paradigms. Our own work on cue-exposure has shown that heroin-related stimuli provoke activation of the anterior cingulate and orbitofrontal regions. Brain metabolism has also been shown to increase in drug withdrawal from alcohol and cocaine. Neurotransmitter studies have shown that in alcohol dependence, GABA(A)-benzodiazepine (GABA-BDZ) receptors are reduced in a number of brain regions and suggest that there may be 'capacity within the system' in some benzodiazepine functions, but tolerance to others, e.g., time asleep. Finally, 11C-Ro15-4513 offers new opportunities for imaging the GABA-BDZ system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14636961     DOI: 10.1016/j.euroneuro.2003.08.006

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  13 in total

Review 1.  Modeling relapse in animals.

Authors:  Rémi Martin-Fardon; Friedbert Weiss
Journal:  Curr Top Behav Neurosci       Date:  2013

Review 2.  Possible Role of CRF-Hcrt Interaction in the Infralimbic Cortex in the Emergence and Maintenance of Compulsive Alcohol-Seeking Behavior.

Authors:  Jung S Kim; Rémi Martin-Fardon
Journal:  Alcohol Clin Exp Res       Date:  2020-01-02       Impact factor: 3.455

Review 3.  Addiction circuitry in the human brain.

Authors:  Nora D Volkow; Gene-Jack Wang; Joanna S Fowler; Dardo Tomasi
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011-09-27       Impact factor: 13.820

4.  Neurocognitive characterizations of Russian heroin addicts without a significant history of other drug use.

Authors:  Diana H Fishbein; Evgeny Krupitsky; Barbara A Flannery; Doris J Langevin; Georgiy Bobashev; Elena Verbitskaya; Cynthia B Augustine; Karen I Bolla; Edwin Zvartau; Barry Schech; Valentina Egorova; Natali Bushara; Marina Tsoy
Journal:  Drug Alcohol Depend       Date:  2007-03-26       Impact factor: 4.492

Review 5.  Addiction: beyond dopamine reward circuitry.

Authors:  Nora D Volkow; Gene-Jack Wang; Joanna S Fowler; Dardo Tomasi; Frank Telang
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-14       Impact factor: 11.205

6.  Identifying the molecular basis of inhibitory control deficits in addictions: neuroimaging in non-human primates.

Authors:  Stephanie M Groman; J David Jentsch
Journal:  Curr Opin Neurobiol       Date:  2013-03-22       Impact factor: 6.627

Review 7.  Neuropathology of substance use disorders.

Authors:  Jean Lud Cadet; Veronica Bisagno; Christopher Mark Milroy
Journal:  Acta Neuropathol       Date:  2013-11-29       Impact factor: 17.088

8.  Brain mu-opioid receptor binding: relationship to relapse to cocaine use after monitored abstinence.

Authors:  David A Gorelick; Yu Kyeong Kim; Badreddine Bencherif; Susan J Boyd; Richard Nelson; Marc L Copersino; Robert F Dannals; J James Frost
Journal:  Psychopharmacology (Berl)       Date:  2008-09-02       Impact factor: 4.530

Review 9.  Serotonergic mechanisms in addiction-related memories.

Authors:  Bríd A Nic Dhonnchadha; Kathryn A Cunningham
Journal:  Behav Brain Res       Date:  2008-07-01       Impact factor: 3.332

Review 10.  The neuropsychology of amphetamine and opiate dependence: implications for treatment.

Authors:  Karen D Ersche; Barbara J Sahakian
Journal:  Neuropsychol Rev       Date:  2007-08-10       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.